# A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome

> **NCT04940624** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 144 (actual)

## Conditions studied

- Dravet Syndrome (DS)

## Interventions

- **DRUG:** Soticlestat
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04940624
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-28
- **Primary completion:** 2024-04-11
- **Final completion:** 2024-04-11
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2025-01-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04940624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04940624, "A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT04940624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*